Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy…
| Price | $18.59 |
|---|---|
| Market cap | $1.14B |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |
| Exchange | NASDAQ |
| 52-week range | 10.28-25.61 |
| Beta | 2.12 |
Explore OMDA's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.